(Q36964709)

17 August 2017

1 reference

title

Oxcarbazepine in neuropathic pain (English)

1 reference

17 August 2017

0 references

Wassim Nasreddine

1

1 reference

17 August 2017

Ahmad Beydoun

series ordinal

2

1 reference

17 August 2017

language of work or name

English

0 references

publication date

1 October 2007

1 reference

Expert Opinion on Investigational Drugs

17 August 2017

published in

1 reference

17 August 2017

volume

16

1 reference

17 August 2017

issue

10

1 reference

17 August 2017

page(s)

1615-1625

1 reference

Painful peripheral neuropathies

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1615

Painful diabetic polyneuropathy: epidemiology, pain description, and quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1615

A comparison of the SF-36 and Nottingham Health Profile in patients with chronic neuropathic pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1615

Differential influence of local anesthetic upon two models of experimentally induced peripheral mononeuropathy in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1615

Epidemiology of refractory neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1615

Acute severe low back pain. A population-based study of prevalence and care-seeking.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1615

Clinical characteristics and economic costs of patients with painful neuropathic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1615

Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1615

A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1615

A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1615

Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1615

Gabapentin for the Treatment of Postherpetic Neuralgia: A Randomized Controlled Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1615

Lamotrigine reduces painful diabetic neuropathy: a randomized, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1615

Pregabalin relieves symptoms of painful diabetic neuropathy: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1615

Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1615

The nature of opioid responsiveness and its implications for neuropathic pain: new hypotheses derived from studies of opioid infusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1615

Treatment of epilepsy in adults: expert opinion, 2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1615

A double-blind study comparing oxcarbazepine and carbamazepine in patients with newly diagnosed, previously untreated epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1615

Interactions between antiepileptic drugs and hormonal contraception

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1615

Oxcarbazepine: mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1615

Comparative anticonvulsant and mechanistic profile of the established and newer antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1615

Oxcarbazepine: preclinical anticonvulsant profile and putative mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1615

What is the evidence that oxcarbazepine and carbamazepine are distinctly different antiepileptic drugs?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1615

Inhibitory effect of oxcarbazepine on high-frequency firing in peripheral nerve fibers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1615

Overview of the clinical pharmacokinetics of oxcarbazepine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1615

Clinical pharmacokinetics of oxcarbazepine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1615

Comparative activity of the anti-convulsants oxcarbazepine, carbamazepine, lamotrigine and gabapentin in a model of neuropathic pain in the rat and guinea-pig

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1615

The suppressive effects of oxcarbazepine on mechanical and cold allodynia in a rat model of neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1615

Oxcarbazepine in painful diabetic neuropathy: a randomized, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1615

Oxcarbazepine in painful diabetic neuropathy: results of a dose-ranging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1615

Oxcarbazepine: a new drug in the management of intractable trigeminal neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1615

Trigeminal neuralgia: its treatment with two new carbamazepine analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1615

Oxcarbazepine is effective and safe in the treatment of neuropathic pain: pooled analysis of seven clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1615

Safety and tolerability of oxcarbazepine in elderly patients with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1615

Effects of oxcarbazepine on sodium concentration and water handling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1615

Statistics notes: Absence of evidence is not evidence of absence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1615

Clinically important changes in acute pain outcome measures: a validation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1615

Mechanistic Stratification of Antineuralgic Agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1615

10.1517/13543784.16.10.1615

21 January 2018

Identifiers

DOI

1 reference

17 August 2017

1 reference